Tongue hyperpigmentation during interferon-alpha and ribavirin therapy

European Journal of Dermatology

Volumn 19, Issue 3, 2009, Pages 291-292

  Aguayo Leiva, Ingrid ^a   Pérez, Bibiana ^a   Salguero, Irene ^a   Jaén, Pedro ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; CASE REPORT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERPIGMENTATION; LETTER; TONGUE;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPERPIGMENTATION; INTERFERON-ALPHA; MIDDLE AGED; RIBAVIRIN; TONGUE DISEASES;

EID: 66449114318     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2009.0665     Document Type: Letter

References (6)

1. Willems M, Munte K, Vrolijk JM, Den Hollander JC, Böhm M, Kemmeren MH, et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003; 149: 390-394
2. Gurguta C, Kauer C, Bergholz U, Formann E, Steindl-Munda P, Ferenci P. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol 2006; 101: 197-198
3. Fernández A, Vázquez S, Rodríguez-González L. Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol 2008: 18.
4. Sookoian S, Neglia V, Castaño G, Frider B, Kien MC, Chohuela E. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000-1001
5. Sood A, Midha V, Bansal M, Goyal A, Sharma N. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J Gastroenterol 2006; 25: 324.
6. Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol 2007; 102: 1334-1335